Known For
Recent Appearances
✨
Early advanced therapy for HS can limit disease progression and tissue destruction.
✨
HS care involves symptom assessment, comorbidity screening, and wound management.
✨
JAK inhibitors have distinct roles for topical and oral vitiligo treatment.
✨
Ritlecitinib stabilizes vitiligo, offering meaningful outcomes.
✨
Ritlecitinib shows promise for non-segmental vitiligo based on late-breaking data.